Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 4/2010

01-08-2010 | Correspondence

Pancytopenia in a patient with Lyme disease

Authors: V. Babu, S. Sukumarannair, Z. Saul

Published in: Infection | Issue 4/2010

Login to get access

Excerpt

Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in USA [1]. Its most frequent clinical features include skin manifestations and fever [2]. Hematologic manifestations are unusual in solitary infections with B burgdorferi. We report what we believe is the first documented case of pancytopenia triggered by Lyme disease. …
Literature
1.
Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease: United States 1992–2006. MMWR Surveiill Summ. 2008;57:1–9.
2.
Petersen LR, Sweeney AL, Checko PJ, et al. Epidemiological and clinical features of 1149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut. Yale J Biol Med. 1989;62:253–62.PubMed
3.
Duray PH, Steere AC. Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci. 1988;539:65–79.CrossRefPubMed
4.
Kvasnicka HM, Thiele J, Ahmadi T. Bone marrow manifestation of Lyme disease. Br J Hematol. 2003;120:723.CrossRef
5.
Gunthard HF, Peter O, Gubler J. Leukopenia and thrombocytopenia in a patient with early Lyme borreliosis. Clin Infect Dis. 1996;22:1119–20.PubMed
6.
Ballard HS, Bottino G, Bottino J. The association of thrombocytopenia and Lyme disease. Postgradmed J. 1994;70:285–7.CrossRef
Metadata
Title
Pancytopenia in a patient with Lyme disease
Authors
V. Babu
S. Sukumarannair
Z. Saul
Publication date
01-08-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 4/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0010-7

Other articles of this Issue 4/2010

Infection 4/2010 Go to the issue

Clinical and Epidemiological Study

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules

Clinical and Epidemiological Study

Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection

Correspondence

Psychiatric manifestations as the leading symptom in an expatriate with dengue fever

Brief Report

Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite persistent elevated C-reactive protein values

Case Report

Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis

Clinical and Epidemiological Study

Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits